Aiza Ali Mbbs Akbar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aiza Ali Mbbs Akbar has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alif Hasan Pranto
School of Pharmacy, Brac University, Dhaka 1212, Bangladesh
1 shared publication Amir Iqbal Mbbs Ali
Combined Military Hospital/SKBZ, Muzaffarabad, AJK, Pakistan
1 shared publication- Amna Akbar
Emergency and Accident, District Headquarter Hospital, Muzaffarabad, PAK
1 shared publication - Attarab Mbbs Shakeel
Azad Jammu & Kashmir Medical College, Muzaffarabad, Pakistan
1 shared publication - Dewan Zubaer Islam
Department of Microbiology, Jahangirnagar University, Dhaka 1342, Bangladesh
1 shared publication - Ehsan Suez
Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA
1 shared publication
Latest Publications
- Open Access
- 1 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (44) , e40339
Prevalence of HIV/AIDS among pregnant women in North American region: A systematic review and meta-analysis
Background: As a major maternal health concern, the prevalence of human immunodeficiency virus (HIV) among pregnant women was previously investigated in European, African, and Latin American regions other than the North American region. This study analyzed the prevalence of HIV among pregnant women in the North American region including 3 major countries: the USA, Canada, and Mexico. Methods: Relevant studies were screened from 3 online databases: Google Scholar, PubMed, and ScienceDirect using specific search keywords. Ultimately, 10 studies of the North American region were included with a total of 339,831 pregnant women residing in the USA, Canada, and Mexico. Results: The overall pooled prevalence was 0.6% (95% confidence interval [CI]: 0.4–0.8) with a high degree of heterogeneity (I 2 = 97%). Pooled prevalence rates of HIV among pregnant women in Canada, Mexico, and the USA were 0.3% (95% CI: 0.1–0.5), 0.5% (95% CI: 0.2–0.8), and 2.3% (95% CI: 0.0–5.7), respectively with high degrees of heterogeneity. Conclusion: The overall prevalence rate of HIV among pregnant women in the USA, Canada, and Mexico was minimal as compared with the countries of Eastern Europe, sub-Saharan Africa, or Latin America. Awareness, adequate testing and healthcare facilities, better socioeconomic, and geopolitical conditions might be crucial to lowering the prevalence of HIV among pregnant women.
- 1 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (44) , e40339
Open AccessPrevalence of HIV/AIDS among pregnant women in North American region: A systematic review and meta-analysis
Background: As a major maternal health concern, the prevalence of human immunodeficiency virus (HIV) among pregnant women was previously investigated in European, African, and Latin American regions other than the North American region. This study analyzed the prevalence of HIV among pregnant women in the North American region including 3 major countries: the USA, Canada, and Mexico. Methods: Relevant studies were screened from 3 online databases: Google Scholar, PubMed, and ScienceDirect using specific search keywords. Ultimately, 10 studies of the North American region were included with a total of 339,831 pregnant women residing in the USA, Canada, and Mexico. Results: The overall pooled prevalence was 0.6% (95% confidence interval [CI]: 0.4–0.8) with a high degree of heterogeneity (I 2 = 97%). Pooled prevalence rates of HIV among pregnant women in Canada, Mexico, and the USA were 0.3% (95% CI: 0.1–0.5), 0.5% (95% CI: 0.2–0.8), and 2.3% (95% CI: 0.0–5.7), respectively with high degrees of heterogeneity. Conclusion: The overall prevalence rate of HIV among pregnant women in the USA, Canada, and Mexico was minimal as compared with the countries of Eastern Europe, sub-Saharan Africa, or Latin America. Awareness, adequate testing and healthcare facilities, better socioeconomic, and geopolitical conditions might be crucial to lowering the prevalence of HIV among pregnant women.